Novocure Email Format

Medical Equipment Manufacturing
1,001-2,500 employees
Baar, Switzerland

Novocure is a global oncology company developing and commercializing Tumor Treating Fields therapy to extend survival for patients with aggressive cancers including glioblastoma and lung cancer.

Find contacts at Novocure

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@novocure.com

Company Overview

Industry
Medical Equipment Manufacturing
Founded
2000
Headquarters
Baar, Switzerland
Revenue
$500M-$1B
FUNDING Stage
Public
Key Executives
Frank Leonard (Chief Executive Officer), Christoph Brackmann (Chief Financial Officer), Mukund Paravasthu (Chief Operating Officer)

Tech Stack

Salesforce

CRM

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Novocure?

Novocure uses the firstinitiallast format on novocure.com, so Jane Smith would be jsmith@novocure.com.

What approved devices does Novocure currently market for cancer patients?

Novocure markets three FDA-approved wearable devices: Optune Gio for glioblastoma, Optune Lua for metastatic non-small cell lung cancer, and Optune Pax, which received FDA approval in February 2026 for locally advanced pancreatic cancer.

How large is Novocure as a company?

Novocure has approximately 1,495 employees and is headquartered in Baar, Switzerland, with commercial and research operations across multiple countries. Tools like Clay can help you find specific Novocure contacts and verify their email addresses before outreach.

Which cancer types are being studied in Novocure's clinical pipeline beyond approved indications?

Novocure's pipeline includes active phase 3 trials named LUNAR, METIS, PANOVA, and TRIDENT, investigating Tumor Treating Fields across solid tumors such as brain metastases, gastric cancer, liver cancer, and others.

Who leads Novocure's executive team?

Novocure's executive team is led by Frank Leonard as Chief Executive Officer, Christoph Brackmann as Chief Financial Officer, and Mukund Paravasthu as Chief Operating Officer.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles